208 related articles for article (PubMed ID: 24945997)
1. Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study.
Fraser DM; Sullivan FM; Thompson AM; McCowan C
Br J Cancer; 2014 Jul; 111(3):623-7. PubMed ID: 24945997
[TBL] [Abstract][Full Text] [Related]
2. Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.
McCowan C; Munro AJ; Donnan PT; Steele RJ
Eur J Cancer; 2013 Mar; 49(5):1049-57. PubMed ID: 23182687
[TBL] [Abstract][Full Text] [Related]
3. Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort.
Liao SF; Koshiol J; Huang YH; Jackson SS; Huang YH; Chan C; Huang C; Liu PC; Chen YJ; Hsieh RJ; Huang CP; Lu SN; Chen CJ; Shen CY; Lee MH
Hepatology; 2021 Oct; 74(4):1994-2006. PubMed ID: 33942350
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.
Macfarlane TV; Murchie P; Watson MC
Cancer Epidemiol; 2015 Dec; 39(6):1015-22. PubMed ID: 26590503
[TBL] [Abstract][Full Text] [Related]
5. Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study.
Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LJ
Cancer Epidemiol; 2017 Apr; 47():20-27. PubMed ID: 28088656
[TBL] [Abstract][Full Text] [Related]
6. Use of aspirin postdiagnosis improves survival for colon cancer patients.
Bastiaannet E; Sampieri K; Dekkers OM; de Craen AJ; van Herk-Sukel MP; Lemmens V; van den Broek CB; Coebergh JW; Herings RM; van de Velde CJ; Fodde R; Liefers GJ
Br J Cancer; 2012 Apr; 106(9):1564-70. PubMed ID: 22454078
[TBL] [Abstract][Full Text] [Related]
7. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
8. The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients.
van Staalduinen J; Frouws M; Reimers M; Bastiaannet E; van Herk-Sukel MP; Lemmens V; de Steur WO; Hartgrink HH; van de Velde CJ; Liefers GJ
Br J Cancer; 2016 Apr; 114(9):1053-9. PubMed ID: 27115570
[TBL] [Abstract][Full Text] [Related]
9. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT; Willson ML; Goel S; Beith J; Goodwin A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
[TBL] [Abstract][Full Text] [Related]
10. Statin use and breast cancer survival: a nationwide cohort study in Scotland.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
BMC Cancer; 2016 Aug; 16():600. PubMed ID: 27491389
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
[TBL] [Abstract][Full Text] [Related]
12. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Dalton SO; Nørgaard M; Pottegård A; Hallas J; Sørensen HT; Friis S
Ann Intern Med; 2019 Apr; 170(7):443-452. PubMed ID: 30831581
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis.
Huang XZ; Gao P; Sun JX; Song YX; Tsai CC; Liu J; Chen XW; Chen P; Xu HM; Wang ZN
Cancer Causes Control; 2015 Apr; 26(4):589-600. PubMed ID: 25701248
[TBL] [Abstract][Full Text] [Related]
14. Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, Italy.
Ventura L; Miccinesi G; Barchielli A; Manneschi G; Puliti D; Mantellini P; Orso F; Zappa M
Eur J Cancer Prev; 2018 Mar; 27(2):134-139. PubMed ID: 27845951
[TBL] [Abstract][Full Text] [Related]
15. Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.
Cronin-Fenton DP; Heide-Jørgensen U; Ahern TP; Lash TL; Christiansen P; Ejlertsen B; Sørensen HT
Epidemiology; 2016 Jul; 27(4):586-93. PubMed ID: 27007644
[TBL] [Abstract][Full Text] [Related]
16. Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink.
Murray LJ; Cooper JA; Hughes CM; Powe DG; Cardwell CR
Breast Cancer Res; 2014 Apr; 16(2):R34. PubMed ID: 24708725
[TBL] [Abstract][Full Text] [Related]
17. Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer.
Davis JS; Chavez JC; Kok M; San Miguel Y; Lee HY; Henderson H; Overman MJ; Morris V; Kee B; Fogelman D; Advani SM; Johnson B; Parseghian C; Shen JP; Dasari A; Shaw KR; Vilar E; Raghav KP; Shureiqi I; Wolff RA; Meric-Bernstam F; Maru D; Menter DG; Kopetz S; Chang S
JAMA Netw Open; 2022 Oct; 5(10):e2236357. PubMed ID: 36239938
[TBL] [Abstract][Full Text] [Related]
18. Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study.
Wang T; McCullough LE; White AJ; Bradshaw PT; Xu X; Cho YH; Terry MB; Teitelbaum SL; Neugut AI; Santella RM; Chen J; Gammon MD
Cancer; 2019 Nov; 125(21):3836-3844. PubMed ID: 31402456
[TBL] [Abstract][Full Text] [Related]
19. Non-aspirin NSAID use and ovarian cancer mortality.
Verdoodt F; Dehlendorff C; Friis S; Kjaer SK
Gynecol Oncol; 2018 Aug; 150(2):331-337. PubMed ID: 29960709
[TBL] [Abstract][Full Text] [Related]
20. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
